Towards a microfluidics platform for the continuous manufacture of organic and inorganic nanoparticles

Nanomedicine. 2021 Jul:35:102402. doi: 10.1016/j.nano.2021.102402. Epub 2021 Apr 29.

Abstract

In the last decade, microfluidics has opened new avenues for the synthesis of nanomaterials. However, the adoption of this production technique has been limited to a few high-value, low-production-volume organic nanoparticles. While there are several technical factors that can be attributed to this slow adoption, an important aspect to consider is the lack of a unified platform capable of producing a wide range of nanomaterials. In this work, we highlight a micro-mixing platform that can manufacture both organic and in-organic nanoparticles over a wide size range (nm-μm). We show that the platform can predictably and reproducibly create size and shape-controlled formulations with high homogeneity through input flow parameters. We further explore parallelization of this platform and discuss key technical constraints for high-volume production. We believe that the platform presented in this work can accelerate the adoption of nanomaterials relevant to a range of industries that encompass pharmaceutics, diagnostics, and cosmeceuticals.

Keywords: Diagnostics; Manufacturing; Medical imaging; Microfluidic; Nanoparticles; Pharmaceutical.

MeSH terms

  • Lab-On-A-Chip Devices*
  • Microfluidic Analytical Techniques*
  • Nanoparticles / chemistry*